Penicillamine is a chelating agent and disease-modifying antirheumatic drug (DMARD) used to treat several medical conditions, including:
∙ Wilson’s disease (to remove excess copper from the body)
∙ Rheumatoid arthritis (to reduce inflammation and slow disease progression)
∙ Cystinuria (to prevent the formation of kidney stones)
Although its name is similar to penicillin, penicillamine is not an antibiotic, and it does not possess antimicrobial properties. It is a metabolite of penicillin, but its chemical and pharmacological actions are distinct. It works primarily by binding to metals like copper and facilitating their excretion from the body.
Parent: Penicillamine
Parent: Penicillamine
Parent: Penicillamine
Parent: Penicillamine
Parent: Penicillamine
Parent: Penicillamine
Impurities in penicillamine may originate from synthesis, degradation, or formulation processes and must be carefully monitored to comply with ICH, FDA, and pharmacopeial standards for pharmaceutical use.
Process-Related Impurities
Degradation Impurities
Elemental Impurities
Analytical Techniques for Impurity Detection
Penicillamine is classified as: